A Comparative Study of Stem and Cup Fixation and Polyethylene Wear

December 7, 2023 updated by: Umeå University

Link LCU + Lima Delta TT vs DePuy Corail + Pinnacle. A Comparative Study of Stem and Cup Fixation and Polyethylene Wear

A randomized controlled study comparing two types of cementless femoral stems (LCU and Corail) and two types of acetabular components (DeltaTT and Pinnacle Duofix) in primary total hip arthroplasty. Primary outcome are component migration measured by RSA, wear and patient reported outcome. Patients are evaluated up to 15 years postoperatively.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Material Patients The study will be conducted according to GCP, (Good Clinical Practice). Potential clinical study participants will be identified from the THR waiting list of Umeå University Hospital. The enrolment process will involve a review of the patient history from the medical records in order to match available patient details with the inclusion/exclusion criteria (see below). Patients considered suitable for potential study enrolment will be contacted by a member of the research team to ascertain their level of interest in participating in this study.

Once verbal and written informed consent is provided a medical profile will be taken.

Inclusion criteria:

Primary or secondary osteoarthritis of the hip Male and non-pregnant female patients aged 18 to 70 years of age Type A or B femur Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up

Exclusion criteria BMI under 18 and over 35 Inflammatory arthritis Osteoporosis Paget's disease Grossly abnormal hip anatomy (severe dysplasia) Previous operations in the same hip Presence of malignancy Patients who, as judged by the surgeon, are mentally incompetent or are reasonable unlikely to be compliant with the requirements of the study Patient is female of child-bearing age and not taking contraceptive precautions

Implants Control: Corail femoral stem and Pinnacle cup with Marathon XLPE neutral liner (DePuy Orthopaedics), Bilolox delta ceramic femoral head 32 mm Study: LCU femoral stem (Waldemar Link GmbH) and Delta TT cup with Neutral XLPE liner (Lima Corporate), Biolox delta ceramic femoral head 32 mm.

For both designs a 28 mm femoral head will be used when cup size (< 48 mm) precludes the use of larger head.

The stems will be fitted with 2 tantalum markers by the surgeon at the operation. One tantalum marker will be fixed in a small PEEK tower that will be screwed in at the shoulder of the stem. Another tantalum marker will be cemented at the tip of the stem before insertion. The PE liners will be fitted with tantalum beads by the surgeon at the time of surgery.

The shell of the Delta TT cup will have 2 to 3 tantalum markers attached to its outer surface. This process will be done by a subcontractor to the manufacturer.

Randomization Stratification for gender will be done. Within each stratum there will be block randomization with 8 permutations in each block, each permutation will be either LCU+Delta TT, LCU+Pinnacle, Corail+Delta TT, or Corail+Pinnacle. The randomization plan generator available at www.randomization.com will be used to create the randomization which will then be put in consecutively numbered sealed envelopes, one series for each stratum. The envelopes will be located in a locked cabinet at the research nurse office. Due to logistic reasons it will not be possible to open the sealed envelope at the time for surgery. Instead the surgeon the day before surgery calls the research nurse who opens the envelope and assigns the patient name to that randomization. This procedure will ensure that correct instrumentation and implants will be available for surgery.

Operative technique All patients will be operated through a postero-lateral approach. The height of the resection of the collum femoris is determined by preoperative templating. The acetabulum is prepared by reaming in 2 mm increments until a good bone contact is established. The press fit is tested with a trial cup. The recommendation is to use a cup the same size as the last reamer, line-to-line. The aim is 35 to 45 degrees of abduction and 15-20 degrees of anteversion. Additional screws are only used if surgeon considers that absolutely necessery. As standard a neutral liner is used routinely. If no sufficient stability of the hip is established with the neutral liner, a 20° lipped liner is used as a compromise solution. In case of acetabular fracture additional screws may be used but the patient is then excluded from the study.

The femoral canal is opened with a box chisel and a straight rasp is used for identifying the center of the femoral canal. Preparation is always started with the smallest broach. The size of the broach is increased until rotational stability in the preoperatively planed height is reached. A trial reduction, including testing of hip stability, is then performed. When adequate leg length, offset and stability is reached the definitive stem is inserted. If a femoral fracture occurs during operation a collared stem is used together with cerclage wiring and the patient will be excluded from the study. The ceramic head is assembled on to the properly cleaned taper with one firm blow.

9 Tantalum markers will be inserted into the bone of the pelvis around acetabulum and 9 in the proximal femur using a special inserter. Tantalum markers will also be inserted into the polyethylene liner and, in case of Delta TT cup, into the outer surface of the metal cup. Finally 1 tantalum marker affixed to a purposely made PEEK tower will screwed onto the shoulder of the femoral stem and 1 marker cemented onto the tip of the stem.

Intra op measurements Clinical quality of cup and stem insertion (surgeon's judgement): excellent, good, doubtful Degrees of femoral internal rotation at 90 degrees of hip flexion at time for subluxation of femoral head.

Size of last cup and stem reamer/broach All implant parameters

RSA Measurement of polyethylene wear, stem and cup migration and liner-shell fixation is measured with RSA within one week postop, and thereafter at 1½ mo, 3 mo, 12 mo, 24 mo, 5y, 10 y, and 15 y postoperatively.

RSA has been used for implant research for over 30 years, with several hundreds of publications, and is considered the golden standard for this type of research.

At the time of operation tantalum spheres/markers (diameter 1 mm) are inserted into proximal femur, periacetabular area and in the polyethylene liner in a standardized manner. The femoral components will be equipped with 2 tantalum spheres in prefabricated cases.

Conventional x rays AP pelvis and AP + lateral of affected hip will be obtained preop. (for templating), within one week postop. (check and measurement of alignment) and at 12 mo, 24 mo, 5 y, 10 y and 15 y (for determination of osseointegration and osteolysis/stress shielding).

Computed tomography (CT) CT of the pelvis around the cup will be performed 24 months and 5 or 10 years postoperatively to determine potential acetabular osteolysis / bone resorption.

Clinical evaluation Patient reported outcome measures: HOOS, Harris Hip Score, EQ5D, EQ5D VAS, SF-36 and UCLA activity score will be obtained preoperatively, and at all postoperative follow-ups.

Serological measurements Level of serum titanium will be measured preoperative, and at 12 mo, 24 mo, 5y, 10 y, and 15 y postoperative

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
    • Västerbotten
      • Umeå, Västerbotten, Sweden, 901 89
        • Volker TC Otten

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Primary or secondary osteoarthritis of the hip
  • Male and non-pregnant female patients aged 18 to 70 years of age
  • Type A or B femur
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up

Exclusion Criteria:

  • BMI under 18 and over 35
  • Inflammatory arthritis
  • Osteoporosis
  • Paget's disease
  • Grossly abnormal hip anatomy (severe dysplasia)
  • Previous operations in the same hip
  • Presence of malignancy
  • Patients who, as judged by the surgeon, are mentally incompetent or are reasonable unlikely to be compliant with the requirements of the study
  • Patient is female of child-bearing age and not taking contraceptive precautions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Stem components
Randomization between two stem components. LCU or Corail stem.
Device: Randomization between prosthetic components
Patients are randomized between two types of stem components and two types of cup components in total hip arthroplasty. Thus randomized between 4 different groups.
Active Comparator: Cup components
Randomization between two cup components. DeltaTT or Pinnacle cup.
Device: Randomization between prosthetic components
Patients are randomized between two types of stem components and two types of cup components in total hip arthroplasty. Thus randomized between 4 different groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cup Migration
Time Frame: 1-15 years
Migration measured in millimetres per year with radiostereometric (RSA) analysis of radiographs. Radiostereometric analysis (RSA) is a stereo X-ray technique used in clinical research studies to evaluate micro-motion and wear of orthopaedic implants within bone. The method has a high accuracy and precision. Technical requirements include the need for implanted marker beads and radiograph view angles determined by a calibration cage.
1-15 years
Femoral stem migration
Time Frame: 1-15 years
Migration measured in millimetres per year with radiostereometric (RSA) analysis of radiographs.
1-15 years
Wear
Time Frame: 1-15 years
The size of the femoral component penetration into the polyethylene measured in millimeters per year and the volumetric annual wear millimetres with radiostereometric (RSA) analysis of radiographs.
1-15 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movement between liner and acetabular components
Time Frame: 1-15 years
Movements between the polyethylene liner and the metal shell of the Delta TT millimetres with radiostereometric (RSA) analysis of radiographs measured in millimeters per year.
1-15 years
Patient reported outcome measurement
Time Frame: 1-15 years
Hip disability and Osteoarthritis Outcome Score is a disease specific patient reported outcome measures ranging from 0-100 points. Obtained preoperatively, and at all postoperative follow-ups 6 weeks, 3, 12 months, 2, 5, 10 and 15 years.
1-15 years
Harris Hip Score
Time Frame: 1-15 years
Harris Hip score is a patient reported outcome measure which include questions regarding the function of the treated hip. Obtained preoperatively, and at all postoperative follow-ups 6 weeks, 3, 12 months, 2, 5, 10 and 15 years.
1-15 years
EQ5D
Time Frame: 1-15 years
A general health related quality of life questionnaire of which a score i calculated (-0,594-1.0). Obtained preoperatively, and at all postoperative follow-ups 6 weeks, 3, 12 months, 2, 5, 10 and 15 years.
1-15 years
Visual Analog Scale
Time Frame: 1-15 years
Visual Analog Scale (0-100 points) obtained preoperatively, and at all postoperative follow-ups 6 weeks, 3, 12 months, 2, 5, 10 and 15 years.
1-15 years
University of California, Los Angeles (UCLA) activity scale
Time Frame: 1-15 years
Patient reported outcome measure for evaluating activity University of California, Los Angeles (UCLA) activity scale (0-10). Obtained preoperatively, and at all postoperative follow-ups 6 weeks, 3, 12 months, 2, 5, 10 and 15 years.
1-15 years
Short Form Health Survey
Time Frame: 1-15 years
Short Form Health Survey (0-100 points) is a general health related quality of life patient reported outcome measure Obtained preoperatively, and at all postoperative follow-ups 6 weeks, 3, 12 months, 2, 5, 10 and 15 years.
1-15 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Umeå University

Investigators

  • Principal Investigator: Volker TC Otten, M.D., Ph.D, Umea University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

September 30, 2020

Study Completion (Estimated)

November 30, 2033

Study Registration Dates

First Submitted

April 23, 2019

First Submitted That Met QC Criteria

August 20, 2019

First Posted (Actual)

August 22, 2019

Study Record Updates

Last Update Posted (Actual)

December 14, 2023

Last Update Submitted That Met QC Criteria

December 7, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LCU-DeltaTT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Hip

Clinical Trials on Randomization between prosthetic components

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe